Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Armin Weinberg, Leonard Kalman, Michael Kolodziej

Premium

MolecularHealth has appointed three new members to its advisory board.

Armin Weinberg is CEO of the Life Beyond Cancer Foundation, a clinical professor at Baylor College of Medicine, and an adjunct professor at Rice University and Texas A&M School of Public Health. He was cofounder of the Intercultural Cancer Council and a member of the founding board of C-Change. He holds a PhD from Ohio State University.

Leonard Kalman is a practicing oncologist and serves as chairman of the board of managers of Advanced Medical Specialties. He holds an MD from Duke University School of Medicine.

Michael Kolodziej is the national medical director of oncology strategy at Aetna and was a practicing oncologist for 23 years. He holds an MD from Washington University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.